Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. Methotrexate (MTX) has been described to ...
A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary ...
LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS today presented a late-breaking poster titled “Significant cytotoxic and immunomodulatory effects of continuous low-dose intravesical gemcitabine in rodent ...
Adjuvant chemotherapy prolongs disease-free survival (DFS) and overall survival (OS) following surgery in patients with colorectal cancer. Although it is known that biomodulation of 5-fluorouracil ...